Zobrazeno 1 - 10
of 29
pro vyhledávání: '"BG Dharmanand"'
Autor:
Vineeta Shobha, Chanakya Kodishala, S Chandrashekara, Sharath Kumar, Vikram Haridas, VijayK R Rao, Ramesh Jois, Manisha Daware, YogeshPreet Singh, Shweta Singhai, BG Dharmanand, Pramod Chebbi, R Subramanian, Ashwini Kamath, Uma Karjiigi, VikramRaj K Jain, Chethana Dharmapalaiah, Shiva Prasad, C Srinivasa, Ramya Janardana, Benzeeta Pinto, Beenish Nazir, AS Harshini, KM Mahendranath
Publikováno v:
Indian Journal of Rheumatology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c226873af298bac7444a31aeee2e13a
https://doi.org/10.4103/injr.injr_213_21
https://doi.org/10.4103/injr.injr_213_21
Autor:
K. Sangeetha, Vijay Rao, Yogesh Preet Singh, Manisha Ashwin Daware, Sharath Kumar, S Chandrashekara, Padmanabha Shenoy, Ramya Janardana, Chanakya K, Chandrashekar Srinivasa, Abhishek Patil, Santosh Nagaraj, Vineeta Shobha, Shweta Singhai, BG Dharmanand, Ramesh Jois, Vikramraj K Jain, Ramaswamy Subramaniam, Chethana Dharmapalaiah, Vikram Haridas, Benzeeta Pinto
Publikováno v:
BMC rheumatology. 6(1)
Background We conducted this study to identify the influence of prolonged use of hydroxychloroquine (HCQ), glucocorticoids and other immunosuppressants (IS) on occurrence and outcome of COVID-19 in patients with autoimmune rheumatic diseases (AIRDs).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3280329edc8fd503e0e1732d3b3283c1
https://pubmed.ncbi.nlm.nih.gov/35698182
https://pubmed.ncbi.nlm.nih.gov/35698182
Autor:
BG Dharmanand, Shiva Prasad, Krishnamurthy Anupama, Anu Mohan Desai, Vijay Rao, Uma Karjigi, Manisha Ashwin Daware, Yogesh Preet Singh, S Chandrashekara, Kurugodu Mathada Mahendranath, Vineeta Shobha, Pradeep Kumar, Sharath Kumar, Ramesh Jois, Santosh Nagaraj, Chethana Dharmapalaiah
Publikováno v:
Rheumatology International. 39:497-507
Biologic disease-modifying anti-rheumatic drugs (bDMARD) have transformed the treatment paradigm of chronic autoimmune rheumatic diseases (ARDs), but they are often associated with adverse drug reactions. The present study evaluated the frequency, ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51d8988b03ee648c783de2fdf283d5ad
https://doi.org/10.1007/s00296-019-04245-4
https://doi.org/10.1007/s00296-019-04245-4
Autor:
Vijay Rao, Chandrashekara Srikantiah, Yogesh Preet Singh, Pradeep Kumar, Sharath Kumar, Vineeta Shobha, Anu Mohan Desai, BG Dharmanand, Uma Karjigi, Chethana Dharmapalaiah, Shiva Prasad, Manisha Ashwin Daware, Kurugodu Mathada Mahendranath, Ramesh Jois
Publikováno v:
Indian Journal of Rheumatology, Vol 14, Iss 1, Pp 17-20 (2019)
Introduction: Biologics are widely used in Autoimmune rheumatologic diseases (AIRDs), however the need to capture real life data which monitors indications, adverse reactions cannot be over emphasized. Methods: This is a cross-sectional ambidirection
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e945a1f5e98e90284870957bf98d870e
http://www.indianjrheumatol.com/article.asp?issn=0973-3698
http://www.indianjrheumatol.com/article.asp?issn=0973-3698
Autor:
BG Dharmanand, Ramakrishna Rao Uppuluri, Siddharth Kumar Das, Sarath Chandra Mouli Veeravalli, Elizabeth C. Hsia, Ahmed Khalifa, Sarvajeet Pal, R. Yao, Milind Nadkar, Kaiyin Fei, Vineeta Shobha
Publikováno v:
International Journal of Rheumatic Diseases. 19:1083-1092
Aim To conduct a subgroup analysis of GO-MORE trial Part 1, comparing efficacy and safety of add-on subcutaneous golimumab therapy in rheumatoid arthritis (RA) patients enrolled from and outside India. Methods GO-MORE was an open-label, multicenter,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39a2a7ce79ea8a085ba249a7305804d6
https://doi.org/10.1111/1756-185x.12927
https://doi.org/10.1111/1756-185x.12927
Autor:
Kalpana Babu, BG Dharmanand
Publikováno v:
Indian Journal of Ophthalmology, Vol 68, Iss 9, Pp 1986-1988 (2020)
Indian Journal of Ophthalmology
Indian Journal of Ophthalmology
We report a case of exacerbation of posterior scleritis and orbital pseudotumor in a patient with granulomatosis polyangiitis, with initial rituximab infusion. Modifications in rituximab protocols including reduction in maintenance dose for subsequen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f8cca8c7e299f133ea79d16b507b904
https://doi.org/10.4103/ijo.ijo_1644_20
https://doi.org/10.4103/ijo.ijo_1644_20
Autor:
Vijay Rao, Kurugodu Mathada Mahendranath, Yogesh Preet Singh, Manisha Ashwin Daware, Uma Karjigi, Krishnamurthy Anupama, S Chandrashekara, Anu Mohan Desai, BG Dharmanand, Pradeep Kumar, Vineeta Shobha, Chethana Dharmapalaiah, Shiva Prasad, S. Nagaraj, Ramesh Jois, Sharath Kumar
Publikováno v:
International journal of rheumatic diseases. 22(2)
Aim Tuberculosis (TB) is one of the major adverse events of concern associated with the use of biologics for managing autoimmune inflammatory rheumatic diseases (AIRDs). The study presents the data on incidence of TB in relation to biologic used, scr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::637c04d6d18295c6359ce6f38cbb8df0
https://pubmed.ncbi.nlm.nih.gov/30168281
https://pubmed.ncbi.nlm.nih.gov/30168281
Autor:
BG Dharmanand
Publikováno v:
Poster Presentations.
Background Treatment options for SLE have significant morbidity and mortality. Side effects from corticosteroid usage limit patient adherence and treatment efficacy. B cell depletion appears to target a critical pathophysiological pathway in SLE. Tra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44523c56193a825dd4f4f935701adcde
https://doi.org/10.1136/annrheumdis-2017-eular.2902
https://doi.org/10.1136/annrheumdis-2017-eular.2902
Autor:
Manisha Ashwin Daware, Anupama Swamy, Arun Madhanaghatta Shanthappa, Ramesh Jois, Sharath Kumar, Yogesh Preet Singh, S Chandrashekara, Kurugodu Mathada Mahendranath, Vineeta Shobha, Shiva Prasad, R Subramanian, BG Dharmanand, Vikram Haridas, Srirama Attappa Somashekar, Krishnamurthy Anupama
Publikováno v:
International journal of rheumatic diseases. 22(7)
Aim The use of healthcare resources by rheumatoid arthritis (RA) patients can be related to the presence of disease, comorbid conditions, use of steroids, and the combined use of immunosuppressants. This study evaluated the risk factors associated wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d092143c84a26e1fbd55cdcc1a44759
https://pubmed.ncbi.nlm.nih.gov/30977300
https://pubmed.ncbi.nlm.nih.gov/30977300
Autor:
Anupama Swamy, Vikram Haridas, Manisha Ashwin Daware, Kurugodu Mathada Mahendranath, Yogesh Preet Singh, Srirama Attappa Somashekar, Shiva Prasad, R. Subramanian, Arun Madhanaghatta Shanthappa, Vineeta Shobha, S Chandrashekara, Sharath Kumar, Ramesh Jois, BG Dharmanand, Krishnamurthy Anupama
Publikováno v:
International journal of rheumatic diseases. 21(11)
To study the prevalence of remission in rheumatoid arthritis (RA) patients and the influence of different factors like literacy, socioeconomic status, presence of comorbidity and treatment strategy in achieving remission.The study involved 1990 RA pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ed7f25d73dec6489f1d43544c7b5f56
https://pubmed.ncbi.nlm.nih.gov/27452347
https://pubmed.ncbi.nlm.nih.gov/27452347